CLASS II ONGOING Device recall · Reported 26 Jul 2023 · FDA Enforcement Report

Beckman Coulter DxA Automation System, DxA recalled

Beckman Coulter Biomedical is recalling Beckman Coulter DxA Automation System, DxA 5000, distributed in 17 states. The recall was initiated on 2 Jun 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: (01)15099590707118, All DxA serial numbers
Quantity recalled146 systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2144-2023
FDA event ID
92484
Recalling firm
Beckman Coulter Biomedical, Munchen, N/A
Classification
Class II
Status
Ongoing
Recall initiated
2 Jun 2023
FDA classified
14 Jul 2023
Reported
26 Jul 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

2 Jun 2023Recall initiated by company
14 Jul 2023Classified by FDA+42 days
26 Jul 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A software defect in the DxA Automation System may cause tests to be run on patient samples in tube types not compatible with the requested test, leading to erroneous patient results

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Beckman Coulter DxA Automation System, DxA 5000, REF: B87352, IVD, 200240V, 16A, 50/60HZ, RxOnly

Where it was distributed

US: AL CA FL IL IN KY MI MN MO NE NJ NV NY OH PA SC TX WI WV OUS: Australia, Belgium, Canada, China, Croatia, Czechia, Egypt, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Kazakhstan, Korea, Kuwait, Malaysia, Netherlands, New Zealand, Poland, Saudi Arabia, Spain, Switzerland, United Kingdom,

AlabamaCaliforniaFloridaIllinoisKentuckyMichiganMinnesotaMissouriNebraskaNew JerseyNevadaNew YorkPennsylvaniaSouth CarolinaTexasWisconsinWest Virginia

Questions about this recall

Why was it recalled?

A software defect in the DxA Automation System may cause tests to be run on patient samples in tube types not compatible with the requested test, leading to erroneous patient results

Which lots are affected?

UDI-DI: (01)15099590707118, All DxA serial numbers

Where was it sold?

US: AL CA FL IL IN KY MI MN MO NE NJ NV NY OH PA SC TX WI WV OUS: Australia, Belgium, Canada, China, Croatia, Czechia, Egypt, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Kazakhstan, Korea, Kuwait, Malaysia, Netherlands, New Zealand, Poland, Saudi Arabia, Spain, Switzerland, United Kingdom,

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 92484

This product is part of a recall event; the main page for the event is Beckman Coulter DxA Automation System, DxA 5000 Fit recalled.

More recalls from Beckman Coulter Biomedical

All 7

Other Other Medical Devices recalls

All 13,908